Debra R. Lappin, JD

Debra Lappin serves as a principal with Faegre Baker Daniels Consulting, where she leads the health and biosciences team, and as counsel with Faegre Baker Daniels. She is recognized across government, academic and nonprofit sectors as a leading strategist in health and science policy.

Debra consults on innovative precompetitive partnerships, global consortia and other strategic alliances among academic research institutions, voluntary health agencies, government and industry.

Debra brings special expertise in regulatory science where she leads a range of initiatives for patient engagement in drug development and in the generation of value models for payment and coverage determinations. Drawing upon her understanding of health agency trends, law, ethics and practical funding challenges, Debra is able to deliver advice and creative solutions that position clients to take advantage of the “future state” in the federal enterprise.

Debra is skilled facilitator of scientific meetings, bringing an ability to translate and synthesize complex scientific information for diverse audiences and to elicit collective and balanced input. She is respected and trusted by senior leaders across the nation’s health agencies, having served on advisory boards to the directors of both the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC), as President of the Council for American Medical Innovation, and continuing today as a member of the Board of Research!America.

Faculty Positions:  University of Colorado Health Sciences Center — Department of Medicine, Adjunct Faculty, teaching biomedical ethics in graduate program for clinical research, 1999-2004